Heron Patrick J's Form 4 filing
Arcutis Biotherapeutics, Inc. (ARQT) · filed Oct 26, 2023
- Accession no.
- 0001209191-23-053662
- Filed
- Oct 26, 2023, 4:09 PM ET
- Trade date
- Oct 24, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $200.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Heron Patrick JCIK 0001365617 | Director, 10% Owner |
| Topper James NCIK 0001341382 | 10% Owner |
| Frazier Life Sciences VIII, L.P.CIK 0001655827 | 10% Owner |
| FHM Life Sciences VIII, L.P.CIK 0001698755 | 10% Owner |
| FHM Life Sciences VIII, L.L.C.CIK 0001698823 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2023 | Common Stock | PPurchaseAcquired | +80,000 | $2.50 | +$200,000 | 8,764,232 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.